You have 9 free searches left this month | for more free features.

Suicide gene

Showing 1 - 25 of 6,804

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
Jul 22, 2022

Pancreas Cancer Trial in Seongnam (Theragene arm)

Recruiting
  • Pancreas Cancer
  • Theragene arm
  • Seongnam, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Mar 15, 2021

Glioblastoma, Adult Gliosarcoma, Tumors, Brain Trial in Seongnam (MSC11FCD)

Enrolling by invitation
  • Glioblastoma
  • +4 more
  • Seongnam, Kyunggido, Korea, Republic of
    Bundang CHA Medical Center
Jan 6, 2022

Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

Active, not recruiting
  • Neuroblastoma
  • iC9-GD2 T Cells - frozen
  • +5 more
  • Houston, Texas
  • +1 more
Jan 4, 2023

Melanoma Trial in Ciudad Autónoma de Buenos Aires (Suicide plus immunogene therapy)

Terminated
  • Melanoma
  • Suicide plus immunogene therapy
  • Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
    Hospital Italiano
Feb 21, 2020

Leukemia, Myeloma, Myeloproliferative Diseases Trial in Houston (drug, procedure, behavioral)

Terminated
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 24, 2019

Pancreatic Cancer Trial in Seongnam (Theragene®,Ad5-yCD/mutTKSR39rep-ADP)

Completed
  • Pancreatic Cancer
  • Theragene®,Ad5-yCD/mutTKSR39rep-ADP
  • Seongnam, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Sep 10, 2019

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Brain Tumor, Pediatric, Medulloblastoma, Childhood, Embryonal Tumor Trial (GD2-CART01 (iC9-GD2-CAR T-cells))

Not yet recruiting
  • Brain Tumor, Pediatric
  • +6 more
  • GD2-CART01 (iC9-GD2-CAR T-cells)
  • (no location specified)
Mar 18, 2022

Healthy Volunteers Trial in Limoges (Blood sample)

Completed
  • Healthy Volunteers
  • Blood sample
  • Limoges, France
    Limoges University Hospital
Oct 18, 2021

Self-harm Behaviour Among the Most At-risk Adolescents

Not yet recruiting
  • Self-harm
  • +5 more
  • Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3
  • +12 more
  • Ljubljana, Slovenia
  • +1 more
Mar 13, 2023

Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)

Recruiting
  • Frontotemporal Dementia
  • +3 more
  • Intrathalamic AAV.PGRN administration
  • Intrathalamic AVB-101
  • Katowice, Poland
  • +3 more
Oct 6, 2023

Borderline Personality Disorder Trial in Taipei (Dialectical behavior therapy, Treatment as Usual: any other drug or

Completed
  • Borderline Personality Disorder
  • Dialectical behavior therapy
  • Treatment as Usual: any other drug or psychotherapy offered to participants, except DBT
  • Taipei, Taiwan
    Mackay Memorial Hospital
Sep 2, 2021

Metastatic Pancreatic Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Completed
  • Metastatic Pancreatic Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Hospital
Feb 15, 2022

Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Active, not recruiting
  • Prostate Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Health System
Feb 17, 2022

Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease Trial in United States (VY-AADC01)

Completed
  • Idiopathic Parkinson's Disease
  • +8 more
  • San Francisco, California
  • +3 more
Mar 17, 2022

Major Depression Trial in Montpêllier (Blood sample for genetic purpose)

Completed
  • Major Depression
  • Blood sample for genetic purpose
  • Montpêllier, France
    University Hospital
Dec 21, 2021

Major Depressive Episode, Suicidal and Self-injurious Behavior Trial in Montpellier (Tactile stimulation)

Recruiting
  • Major Depressive Episode
  • Suicidal and Self-injurious Behavior
  • Tactile stimulation
  • Montpellier, France
    Montpellier University Hospital, France (CHU)
Mar 7, 2022

Duchenne Muscular Dystrophy Trial in Los Angeles, Durham, Salt Lake City (PF-06939926)

Active, not recruiting
  • Duchenne Muscular Dystrophy
  • PF-06939926
  • Los Angeles, California
  • +19 more
Dec 12, 2022

Acute Myeloid Leukemia, Multiple Myeloma Trial in Ostrava, Milan, Roma (MLM-CAR44.1 T-cells at day 0 Single intravenous

Terminated
  • Acute Myeloid Leukemia
  • Multiple Myeloma
  • MLM-CAR44.1 T-cells at day 0 Single intravenous infusion
  • Ostrava, Czech Republic, Czechia
  • +2 more
Dec 20, 2021

Treatment Resistant Depression Trial in Louisville (Discontinuation of serotonergic antidepressants, Continuation of

Recruiting
  • Treatment Resistant Depression
  • Discontinuation of serotonergic antidepressants
  • Continuation of serotonergic medications
  • Louisville, Kentucky
    University of Louisville, Department of Psychiatry and Behaviora
May 21, 2022

The Effect of Soluble Epoxide Hydrolase (SEH) on Depression

Recruiting
  • Major Depressive Disorder
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Oct 7, 2022

    CD19-ALL, CD19-LNH Trial in Roma (CD19-CAR T cell)

    Active, not recruiting
    • CD19-ALL
    • CD19-LNH
    • CD19-CAR T cell
    • Roma, Italy
      Ospedale Pediatrico Bambino Gesù
    Mar 9, 2022

    High-risk Prostate Cancer, Prostate Cancer Trial in Houston (drug, radiation, procedure)

    Recruiting
    • High-risk Prostate Cancer
    • Prostate Cancer
    • Houston, Texas
      Houston Methodist Hospital
    Apr 5, 2021